SCHEMBL30309504

SCHEMBL30309504

COc1ccc(N2C(=O)N(c3c(C)cccc3Cl)Cc3cnc(Cl)nc32)nc1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIK2 Q9H0K1 2/20 0.68
CSF1R P07333 1/20 0.62
SIK1 P57059 1/20 0.62
SIK3 Q9Y2K2 1/20 0.62
LCK P06239 1/20 0.39
MAPK14 Q16539 1/20 0.39
FGFR4 P22455 12/20 0.35
FGFR1 P11362 10/20 0.35
NPBWR1 P48145 2/20 0.34
FGFR2 P21802 4/20 0.34
FGFR3 P22607 4/20 0.34
KDR P35968 3/20 0.33
MCHR1 Q99705 1/20 0.33
EGFR P00533 2/20 0.33
PDGFRB P09619 2/20 0.33
PDGFRA P16234 2/20 0.33
FYN P06241 1/20 0.33
MAPK1 P28482 1/20 0.33
EPHB3 P54753 1/20 0.33
GRM5 P41594 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23978372 1.00 SIK2 (0.68) SIK2CSF1RSIK1SIK3LCK
SCHEMBL23978120 0.85 SIK2 (0.51) SIK2CSF1RSIK1SIK3LCK
SCHEMBL30309533 0.85 SIK2 (0.51) SIK2CSF1RSIK1SIK3LCK
SCHEMBL30309511 0.83 SIK2 (0.51) SIK2CSF1RSIK1SIK3FGFR4
SCHEMBL25882388 0.83 SIK2 (0.49) SIK2CSF1RSIK1SIK3FGFR4
SCHEMBL23978178 0.83 SIK2 (0.51) SIK2CSF1RSIK1SIK3FGFR4
SCHEMBL30309560 0.83 SIK2 (0.49) SIK2CSF1RSIK1SIK3FGFR4
SCHEMBL21479327 0.81 SIK2 (0.49) SIK2CSF1RSIK1SIK3FGFR4
SCHEMBL29864908 0.81 SIK2 (0.49) SIK2CSF1RSIK1SIK3FGFR4
SCHEMBL21479238 0.81 SIK2 (1.00) SIK2CSF1RSIK1SIK3LCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4143191-A2 BICYCLIC KINASE INHIBITORS AND USES THEREOF iOmx Therapeutics AG (DE) 2023-03-08 EP disclosed